Maynard Um
-
-
-
-
-
-
-
JPMorgan Downgrades Mereo BipPharma Group (MREO) to Neutral
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $63 at Jefferies
-
-
-
-
-
-
-
Mereo BipPharma Group (MREO) PT Lowered to $1 at Baird
-
-
-
-
-
-
-
Baird Names Mereo BipPharma Group (MREO) a New Fresh Pick into Clinical Data
-
-
-
-
-
-
-
Mereo BioPharma Group plc (MREO) Misses Q1 EPS by 3c
-
-
-
-
-
-
-
Jefferies Starts Mereo BipPharma Group (MREO) at Buy
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE), Mereo BioPharma (MREO) Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) i
-
448,176 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

